Clinical trial SIENDO/ENGOT-EN5
A randomized phase III trial of maintenance with Selinexor / placebo after combination chemotherapy for patients with advanced or recurrent endometrial cancer
| Cancers | |
|---|---|
| Organ | Endometrium |
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 3 |
| Academic trial | Non |
| Sponsor | Karyopharm |
| EudraCT Identifier | 2017-000607-25 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03555422 |
| Last update |